ContraVir Pharmaceuticals

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -77.73% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -79.31% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -77.64% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -78.95% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -78.07% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -73.97% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -76.02% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -74.68% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -72.57% away from its yearly high level, during the last trading session. The

ContraVir Pharmaceuticals, Inc., (NASDAQ: CTRV) was trading -68.99% away from its yearly high level, during the last trading session. The